Home › Funds › DBA TRADING, LLC › LFCR
DBA TRADING, LLC position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
DBA TRADING, LLC reported holding 75,000 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q2 2026 13F filing — a position valued at US$279K, representing 0.14% of its reported portfolio and ranking #31 among its reported holdings. DBA TRADING, LLC has disclosed LFCR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DBA TRADING, LLC's LFCR position evolved
DBA TRADING, LLC first disclosed a stake in LFCR in Q4 2025 at 75,000 shares (US$614K). Across 3 filings, DBA TRADING, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 75,000 shares valued at US$279K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 75.00K | $613.50K | New |
| Q1 2026 | 75.00K | $279.00K | Hold |
| Q2 2026 | 75.00K | $279.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 22 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- WYNNEFIELD CAPITAL INC 4.70M sh · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M sh · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 3.19M sh · $16.75M · Q2 2026
- 325 CAPITAL LLC 2.90M sh · $15.20M · Q2 2026
- DCF Advisers, LLC 424.50K sh · $2.23M · Q2 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 314.01K sh · $1.65M · Q2 2026
More on DBA TRADING, LLC
FAQ
How long has DBA TRADING, LLC held LFCR?
DBA TRADING, LLC has disclosed LFCR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is DBA TRADING, LLC's current position in LFCR?
As of Q2 2026, DBA TRADING, LLC holds 75.00K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $279.00K, representing 0.14% of its reported portfolio and ranking #31.
Has DBA TRADING, LLC been buying or selling LFCR?
In the latest 13F filing (Q2 2026), DBA TRADING, LLC held unchanged its position in LFCR.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.